Dachaigh › Aillse sa bhlaire › Ohio › Cleveland
Sgrùdaidhean clionaigeach Aillse sa bhlaire ann an Cleveland, OH
Tha 18 sgrùdaidhean airson Aillse sa bhlaire a’ lorg phàirtichean aig làraichean ann agus timcheall air Cleveland (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A’ fastadhÌre 1
- University Hospitals Cleveland Medical Center, Cleveland
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
A’ fastadhÌre 1/2
- Cleveland Clinic Taussig Cancer ( Site 5036), Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
A’ fastadhÌre 2
- Cleveland Clinic - Oncology Department, Cleveland
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
A’ fastadhÌre 2
- Cleveland Clinic Taussig Cancer Center, Cleveland
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
A’ fastadhÌre 2
- MetroHealth Medical Center, Cleveland
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
A’ fastadhÌre 1/2
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
A’ fastadhÌre 1
- University Hospitals Cleveland Medical Center, Cleveland
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
A’ fastadhSgrùdadh amharc
- Cleveland Clinic, Cleveland
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
A’ fastadhÌre 2
- Cleveland Clinic, Cleveland
The Vanguard Study: Testing a New Way to Screen for Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- Louis Stokes Cleveland VA Medical Center, Cleveland
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
A’ fastadhÌre 2
- Cleveland Clinic Main Campus, Cleveland, Cleveland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
A’ fastadhÌre 3
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mìle air falbh
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mìle air falbh
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
A’ fastadhÌre 2/3
- Fairview Hospital, Cleveland
- Cleveland Clinic, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mìle air falbh
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
A’ fastadhÌre 3
- Research Site, Cleveland
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A’ fastadhÌre 2
- University Hospitals Cleveland Medical Center, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mìle air falbh
Sgrùdaidhean Aillse sa bhlaire ann am bailtean eile
- New York City, NY35 sgrùdaidhean
- Nashville, TN31 sgrùdaidhean
- Houston, TX31 sgrùdaidhean
- Dallas, TX27 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- Washington, DC26 sgrùdaidhean
- Los Angeles, CA24 sgrùdaidhean
- Baltimore, MD24 sgrùdaidhean
- St. Louis, MO22 sgrùdaidhean
- Philadelphia, PA21 sgrùdaidhean
- Seattle, WA21 sgrùdaidhean
- Edison, NJ21 sgrùdaidhean
Sgrùdaidhean eile ann an Cleveland
- Aillse Sgamhain Neo-chealla-beag43 sgrùdaidhean
- Aillse (gach seòrsa)36 sgrùdaidhean
- Aillse a' bhroilleach35 sgrùdaidhean
- Aillse Prostata34 sgrùdaidhean
- Fàilligeadh a' Chridhe33 sgrùdaidhean
- Ailse metastatach30 sgrùdaidhean
- Cancer Ovarian30 sgrùdaidhean
- Ailseachadh nan Sgamhan26 sgrùdaidhean
- Aillse colorectal24 sgrùdaidhean
- Galarachd Cardiovasculach22 sgrùdaidhean
- Ailse Endometrial20 sgrùdaidhean
- Leukemia myeloid geur20 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.